Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Citi
Medtronic
Express Scripts
QuintilesIMS
AstraZeneca
Colorcon
Julphar
Chubb
Boehringer Ingelheim

Generated: January 23, 2018

DrugPatentWatch Database Preview

LOTENSIN HCT Drug Profile

« Back to Dashboard

US Patents and Regulatory Information for LOTENSIN HCT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Pharms Holdings I LOTENSIN HCT benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 020033-001 May 19, 1992 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Us Pharms Holdings I LOTENSIN HCT benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 020033-003 May 19, 1992 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Us Pharms Holdings I LOTENSIN HCT benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 020033-002 May 19, 1992 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Us Pharms Holdings I LOTENSIN HCT benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 020033-004 May 19, 1992 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for LOTENSIN HCT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharms Holdings I LOTENSIN HCT benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 020033-001 May 19, 1992 ➤ Subscribe ➤ Subscribe
Us Pharms Holdings I LOTENSIN HCT benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 020033-002 May 19, 1992 ➤ Subscribe ➤ Subscribe
Us Pharms Holdings I LOTENSIN HCT benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 020033-004 May 19, 1992 ➤ Subscribe ➤ Subscribe
Us Pharms Holdings I LOTENSIN HCT benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 020033-003 May 19, 1992 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cipla
US Army
AstraZeneca
UBS
Cantor Fitzgerald
Chubb
Argus Health
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot